A Phase 2A, Placebo-Controlled, Randomized Study of ABT-981, an Anti-Interleukin-1Alpha and-1Beta Dual Variable Domain Immunoglobulin, to Treat Erosive Hand Osteoarthritis
Author(s):
Kloppenburg, M.; Peterfy, C.; Haugen, I.K.; Kroon, F.; Chen, S.; Wang, L.; Liu, W.; Levy, G.; Fleischmann, R.; Berenbaum, F.; Heijde, D. van der; Medema, J.K.; Levesque, M.C.
